Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) is projected to issue its results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of $0.7480 per share and revenue of $1.29 billion for the quarter.
Novozymes A/S Stock Performance
NVZMF remained flat at $68.70 on Tuesday. The business’s 50 day moving average is $67.36 and its 200 day moving average is $62.15. Novozymes A/S has a 12-month low of $52.10 and a 12-month high of $73.07.
About Novozymes A/S
Novozymes A/S was a Denmark-based biotechnology company specializing in enzymes and microorganisms for industrial, agricultural, and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource use, and develop more sustainable products and processes.
The company developed and marketed enzyme and microbial solutions for industries including food and beverages, household care, agriculture, bioenergy, animal health, and industrial manufacturing.
Featured Stories
- Five stocks we like better than Novozymes A/S
- Caterpillar’s Sell-Off: Is the Market Missing Its AI Power Play?
- Check Point’s Turnaround Could Be Closer Than Investors Think
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
